MEIP : Summary for MEI Pharma, Inc. - Yahoo Finance

U.S. Markets closed

MEI Pharma, Inc. (MEIP)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.55-0.01 (-0.64%)
At close: 4:00PM EDT
People also watch
OHRPVSTMCNATATNMACRX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.56
Open1.56
Bid1.40 x 20000
Ask2.27 x 1300
Day's Range1.52 - 1.61
52 Week Range1.23 - 2.28
Volume91,825
Avg. Volume205,898
Market Cap57M
Beta2.56
PE Ratio (TTM)-15.35
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • MEI Pharma Announces Appointment of Brian Drazba as Chief Financial Officer
    PR Newswire24 days ago

    MEI Pharma Announces Appointment of Brian Drazba as Chief Financial Officer

    SAN DIEGO, April 3, 2017 /PRNewswire/ -- MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced the appointment of Brian Drazba as Chief Financial Officer. Mr. Drazba joins the Company with more than 25 years of financial management experience in the healthcare industry, most recently as Chief Financial Officer of Heron Therapeutics, Inc., a commercial-stage biotechnology company.

  • MEI Pharma to Present at Needham Healthcare Conference
    PR Newswire29 days ago

    MEI Pharma to Present at Needham Healthcare Conference

    SAN DIEGO, March 28, 2017 /PRNewswire/ -- MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at the Needham Healthcare Conference on Tuesday, April 4, 2017 at 4:20 p.m. Eastern time from the Westin New York Grand Central. MEI Pharma, Inc. (MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.

  • PR Newswirelast month

    MEI Pharma to Present at Oppenheimer Healthcare Conference

    SAN DIEGO, March 14, 2017 /PRNewswire/ -- MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at the Oppenheimer Healthcare Conference on Tuesday, March 21, 2017 at 9:10 a.m. Eastern time from the Westin New York Grand Central. MEI Pharma, Inc. (MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.